These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 17587477)

  • 1. Interleukin-6 levels and HPA axis activation in breast cancer patients with major depressive disorder.
    Soygur H; Palaoglu O; Akarsu ES; Cankurtaran ES; Ozalp E; Turhan L; Ayhan IH
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Aug; 31(6):1242-7. PubMed ID: 17587477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HPA-axis regulation at in-patient admission is associated with antidepressant therapy outcome in male but not in female depressed patients.
    Binder EB; Künzel HE; Nickel T; Kern N; Pfennig A; Majer M; Uhr M; Ising M; Holsboer F
    Psychoneuroendocrinology; 2009 Jan; 34(1):99-109. PubMed ID: 18829172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cortisol circadian rhythm alterations in psychotic major depression.
    Keller J; Flores B; Gomez RG; Solvason HB; Kenna H; Williams GH; Schatzberg AF
    Biol Psychiatry; 2006 Aug; 60(3):275-81. PubMed ID: 16458262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dex/CRH-test response and sleep in depressed patients and healthy controls with and without vulnerability for affective disorders.
    Friess E; Schmid D; Modell S; Brunner H; Lauer CJ; Holsboer F; Ising M
    J Psychiatr Res; 2008 Oct; 42(14):1154-62. PubMed ID: 18281062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Longitudinal neuroendocrine changes assessed by dexamethasone/CRH and growth hormone releasing hormone tests in psychotic depression.
    Owashi T; Otsubo T; Oshima A; Nakagome K; Higuchi T; Kamijima K
    Psychoneuroendocrinology; 2008 Feb; 33(2):152-61. PubMed ID: 18068306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lithium augmentation increases post-dexamethasone cortisol in the dexamethasone suppression test in unipolar major depression.
    Bschor T; Baethge C; Adli M; Eichmann U; Ising M; Uhr M; Müller-Oerlinghausen B; Bauer M
    Depress Anxiety; 2003; 17(1):43-8. PubMed ID: 12577277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Defining the boundaries of atypical depression: evidence from the HPA axis supports course of illness distinctions.
    Stewart JW; Quitkin FM; McGrath PJ; Klein DF
    J Affect Disord; 2005 Jun; 86(2-3):161-7. PubMed ID: 15935235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Different activation patterns of proinflammatory cytokines in melancholic and non-melancholic major depression are associated with HPA axis activity.
    Kaestner F; Hettich M; Peters M; Sibrowski W; Hetzel G; Ponath G; Arolt V; Cassens U; Rothermundt M
    J Affect Disord; 2005 Aug; 87(2-3):305-11. PubMed ID: 15951024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of IL-6, hypothalamus-pituitary-adrenal axis function, and depression in patients with cancer.
    Jehn CF; Kühnhardt D; Bartholomae A; Pfeiffer S; Schmid P; Possinger K; Flath BC; Lüftner D
    Integr Cancer Ther; 2010 Sep; 9(3):270-5. PubMed ID: 20702499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HPA axis activation in major depression and response to fluoxetine: a pilot study.
    Young EA; Altemus M; Lopez JF; Kocsis JH; Schatzberg AF; DeBattista C; Zubieta JK
    Psychoneuroendocrinology; 2004 Oct; 29(9):1198-204. PubMed ID: 15219644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypothalamus-pituitary-adrenal system regulation and suicidal behavior in depression.
    Pfennig A; Kunzel HE; Kern N; Ising M; Majer M; Fuchs B; Ernst G; Holsboer F; Binder EB
    Biol Psychiatry; 2005 Feb; 57(4):336-42. PubMed ID: 15705348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Co-occurring manic symptomatology influences HPA axis alterations in depression.
    Jabben N; Nolen WA; Smit JH; Vreeburg SA; Beekman AT; Penninx BW
    J Psychiatr Res; 2011 Sep; 45(9):1208-13. PubMed ID: 21450306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of gene-gender effects of adrenergic polymorphisms on hypothalamic-pituitary-adrenal axis activity in depressed patients.
    Haefner S; Baghai TC; Schule C; Eser D; Spraul M; Zill P; Rupprecht R; Bondy B
    Neuropsychobiology; 2008; 58(3-4):154-62. PubMed ID: 19088492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The influence of psychiatric comorbidity on the dexamethasone/CRH test in major depression.
    Veen G; Derijk RH; Giltay EJ; van Vliet IM; van Pelt J; Zitman FG
    Eur Neuropsychopharmacol; 2009 Jun; 19(6):409-15. PubMed ID: 19327969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma corticosterone, dexamethasone (DEX) suppression and DEX/CRH tests in a rat model of genetic vulnerability to depression.
    Steimer T; Python A; Schulz PE; Aubry JM
    Psychoneuroendocrinology; 2007 Jun; 32(5):575-9. PubMed ID: 17512120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationships of DEX/CRH and GHRH test results to the outcome of depression--preliminary results suggest the GHRH test may predict relapse after discharge.
    Owashi T; Otsubo T; Oshima A; Nakagome K; Higuchi T; Kamijima K
    J Psychiatr Res; 2008 Apr; 42(5):356-64. PubMed ID: 17412362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cortisol hypersecretion in unipolar major depression with melancholic and psychotic features: dopaminergic, noradrenergic and thyroid correlates.
    Duval F; Mokrani MC; Monreal-Ortiz JA; Fattah S; Champeval C; Schulz P; Macher JP
    Psychoneuroendocrinology; 2006 Aug; 31(7):876-88. PubMed ID: 16769179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biomarkers of depression in cancer patients.
    Jehn CF; Kuehnhardt D; Bartholomae A; Pfeiffer S; Krebs M; Regierer AC; Schmid P; Possinger K; Flath BC
    Cancer; 2006 Dec; 107(11):2723-9. PubMed ID: 17036362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hypothalamic-pituitary-adrenal and hypothalamic-pituitary-thyroid axis findings in depressive disorder].
    Sarandöl A; Taneli B; Sivrioğlu Y
    Turk Psikiyatri Derg; 2003; 14(2):116-24. PubMed ID: 12844278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute cortisol administration increases sleep depth and growth hormone release in patients with major depression.
    Schmid DA; Brunner H; Lauer CJ; Uhr M; Yassouridis A; Holsboer F; Friess E
    J Psychiatr Res; 2008 Oct; 42(12):991-9. PubMed ID: 18226817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.